StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2017, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 14 Apr 2016 14:09:55 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday GenSight Biologics (GNST) Files to Withdraw IPO http://www.streetinsider.com/IPOs/GenSight+Biologics+%28GNST%29+Files+to+Withdraw+IPO/11503740.html Visit StreetInsider.com at http://www.streetinsider.com/IPOs/GenSight+Biologics+%28GNST%29+Files+to+Withdraw+IPO/11503740.html for the full story. http://www.streetinsider.com/IPOs/GenSight+Biologics+%28GNST%29+Files+to+Withdraw+IPO/11503740.html Thu, 14 Apr 2016 14:09:55 -0400 GNST Form RW GENSIGHT BIOLOGICS S.A. http://www.streetinsider.com/SEC+Filings/Form++RW+++++++++GENSIGHT+BIOLOGICS+S.A.++++++++++++++/11503701.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++RW+++++++++GENSIGHT+BIOLOGICS+S.A.++++++++++++++/11503701.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++RW+++++++++GENSIGHT+BIOLOGICS+S.A.++++++++++++++/11503701.html Thu, 14 Apr 2016 14:01:00 -0400 GNST GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html for the full story. http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Mon, 29 Feb 2016 07:00:00 -0400 A.31199512 A.32864876 GNST GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html for the full story. http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Mon, 29 Feb 2016 07:00:00 -0400 A.31199512 A.32864876 GNST GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html for the full story. http://www.streetinsider.com/Press+Releases/GenSight+Biologics+Enrolls+First+Patient+in+Pivotal+Phase+III+Program+of+GS010+in+Leber%E2%80%99s+Hereditary+Optic+Neuropathy/11369116.html Mon, 29 Feb 2016 07:00:00 -0400 A.31199512 A.32864876 GNST UPDATE: GenSight Biologics S.A. (GNST) Files $100M Common Stock IPO http://www.streetinsider.com/IPOs/UPDATE%3A+GenSight+Biologics+S.A.+%28GNST%29+Files+%24100M+Common+Stock+IPO/10710562.html Visit StreetInsider.com at http://www.streetinsider.com/IPOs/UPDATE%3A+GenSight+Biologics+S.A.+%28GNST%29+Files+%24100M+Common+Stock+IPO/10710562.html for the full story. http://www.streetinsider.com/IPOs/UPDATE%3A+GenSight+Biologics+S.A.+%28GNST%29+Files+%24100M+Common+Stock+IPO/10710562.html Wed, 08 Jul 2015 15:42:07 -0400 GNST